*InvestingPro Notes
+Management has been aggressively buying back shares
-Analysts anticipate sales decline in the current year
+Prominent player in the Insurance industry
/Short term obligations exceed liquid assets

**Analyst Targets
17 analysts
$84,41
***Investing Models
5 models
$97,7

Metric Name Value
Market Cap (Adjusted)
45.435 B
Price / Book
1.0x
Avg Price / Book (10y)
0.8x
Predicted Price / Book
1.0x
P/E Ratio
11.9x
Avg P/E Ratio (10y)
0.2x
EV / EBITA
11.8x
Avg EV / EBITDA (10y)
9.7x
Market Cap / LTM Revenue
1.0x
Revenue Growth
38.8%
Revenue Growth Forecast
-42.3%
Revenue
45.299 B
Net Income to Company
-2.3 B
EBITDA
8.501 B
EBITDA Growth
8.5%
EBITDA CAGR (5y)
3.6%
EBITDA Growth Forecast
13.0%
Common Equity
45.039 B
Total Debt / Total Capital
18.1%
Current Ratio
0.6x
Dividend Yield
2.2%
Operating Income Trend Score
25.0%

🎁Great Opportunity! Be one step ahead in the world of investment with Investing Pro+! Now with a channel-specific +15% discount and a total of 70%, don't miss this opportunity! 📈
CODE: sepethissepro

We wish you success in your investments.
AIGFundamental AnalysisTechnical IndicatorsnysestocktradingTrend Analysis

Aynı zamanda::

Feragatname